What is Selective Dorsal Cryoablation?
Selective dorsal cryoablation is a non-surgical, innovative medical procedure used to treat chronic or primary premature ejaculation in men. The core principle of this method involves temporarily blocking sensory transmission by freezing specific branches of the dorsal penile nerves, thereby reducing hypersensitivity. Unlike surgical neurectomy, this technique is reversible and carries a significantly lower risk of permanent complications.
How Does the Procedure Work?
Performed under local anesthesia, the procedure utilizes a specialized cryoprobe to apply extreme cold to the targeted dorsal nerve fibers. This freezing process induces temporary neuropraxia, interrupting nerve signals without permanently damaging the nerve sheath. As a result, penile hypersensitivity is managed, allowing for better ejaculatory control.
Who is a Suitable Candidate?
This treatment is generally recommended for men who meet the following clinical criteria:
- Diagnosed with primary penile hypersensitivity
- Unresponsive to behavioral therapies or topical anesthetic creams
- Seeking to avoid the systemic side effects of oral medications
- Reluctant to undergo permanent surgical dorsal neurectomy
Advantages of the Treatment
Compared to conventional treatment modalities, selective cryoablation offers several distinct clinical benefits:
- Reversible Nature: The nerves are not cut; normal nerve conduction gradually restores over time.
- Minimal Downtime: As a stitch-free, minimally invasive procedure, recovery is swift.
- Preserved Erectile Function: The target is strictly sensory nerves, leaving motor nerves and vascular structures responsible for erection unaffected.
- Long-lasting Efficacy: Provides sustained sensitivity control for months, unlike daily topical applications.
Procedure and Post-Treatment Recovery
The cryoablation procedure takes approximately 30 to 45 minutes in a clinical setting. Patients are discharged on the same day. Mild swelling or localized discomfort may occur, resolving within a few days. Resuming sexual activity is typically permitted within 1 to 2 weeks, depending on clinical evaluation and healing progress.